Results Presented as an Oral Presentation
Crestwood, KY, May 21, 2019 – Liberate Medical, a clinical-stage medical device company, developing novel electrical muscle stimulation devices that non-invasively address pulmonary conditions, today announced the results from its recently completed pilot trial of the VentFree Muscle Stimulator during an oral presentation at the American Thoracic Society International Conference (“ATS”) in Dallas, TX.
The VentFree Muscle Stimulator, which received Breakthrough Device Designation from the FDA in January, is an electrotherapy device that applies stimulation to the abdominal wall muscles in synchrony with mechanical ventilation. It’s designed to prevent abdominal muscle atrophy and reduce the time to wean patients from mechanical ventilation.
The pilot trial, conducted in collaboration with Neuroscience Research Australia at the…